Global Phenylketonuria Market Size & Outlook, 2026-2034

Global Phenylketonuria Market Insights

According to Reed Intelligence analysis, the Global Phenylketonuria Market size was USD 1320 Million in 2025 and is projected to reach USD 2271.98 Million by 2034.
The Global market is projected to grow at a CAGR of 6.3% between 2026 and 2034.
By segment, Enzyme Replacement Therapy emerged as the largest By Treatment Type in terms of market size in 2025.
Medication is anticipated to remain the most attractive By Treatment Type segment, recording the fastest growth during the forecast period.

Other Key Findings

By 2034, United States is anticipated to capture the largest share of the global Phenylketonuria Market.
In Global, Asia Pacific is expected to lead the regional Phenylketonuria Market size by 2034.
Middle East and Africa will remain the fastest-growing market in Global, reaching USD 190.33 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 1320 Million
Market Size In 2034	USD 2271.98 Million
Largest segment	Enzyme Replacement Therapy
Units	Revenue in USD Million
CAGR	6.3% (2026-2034)
Segmnetation Covered
Region	North America Europe Asia Pacific Middle East and Africa LATAM
By Treatment Type	Enzyme Replacement Therapy Gene Therapy Medication Dietary Therapy
By Diagnosis	Genetic Testing Biochemical Testing Newborn Screening
By End-User	Specialty Clinics Research Institutes Home Healthcare Hospitals
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Global Phenylketonuria Market Region 2026-2034 (USD Million)

Region	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
North America	XX.x	XX.x	XX.x	396.53	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Europe	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Asia Pacific	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Middle East and Africa	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
LATAM	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Global Phenylketonuria Market By Treatment Type 2026-2034 (USD Million)

By Treatment Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Enzyme Replacement Therapy	XX.x	XX.x	XX.x	655.91	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gene Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Medication	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dietary Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Global Phenylketonuria Market By Diagnosis 2026-2034 (USD Million)

By Diagnosis	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Genetic Testing	XX.x	XX.x	XX.x	673.86	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biochemical Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Newborn Screening	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Global Phenylketonuria Market By End-User 2026-2034 (USD Million)

By End-User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Specialty Clinics	XX.x	XX.x	XX.x	629.51	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Home Healthcare	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hospitals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.